FDA Inspection 1103377 — Syngene International Ltd.
The FDA completed an inspection of Syngene International Ltd. on August 21, 2019 in Bengaluru. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 21, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bengaluru (India)